PART I Overview LifeVantage Corporation (the Company, LifeVantage, we, us, or our) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to our ...
Q2 FY2026 — expected 2026-09-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-09-04 | 2025-06-30 | 0000849146-25-000068 | EDGAR | 58K words |
| 2024-08-28 | 2024-06-30 | 0000849146-24-000073 | EDGAR | — |
| 2023-08-28 | 2023-06-30 | 0000849146-23-000102 | EDGAR | — |
| 2022-08-23 | 2022-06-30 | 0000849146-22-000058 | EDGAR | — |
| 2021-08-19 | 2021-06-30 | 0000849146-21-000078 | EDGAR | — |
| 2020-08-18 | 2020-06-30 | 0000849146-20-000115 | EDGAR | — |
| 2019-08-14 | 2019-06-30 | 0000849146-19-000063 | EDGAR | — |
| 2018-08-15 | 2018-06-30 | 0000849146-18-000074 | EDGAR | — |
| 2017-09-07 | 2017-06-30 | 0000849146-17-000094 | EDGAR | — |
| 2016-12-12 | 2016-06-30 | 0000849146-16-000207 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-04 | 2025-12-31 | 0001628280-26-005428 | EDGAR | 19K words |
| 2025-11-04 | 2025-09-30 | 0001628280-25-048792 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000849146-25-000039 | EDGAR | — |
| 2025-02-05 | 2024-12-31 | 0000849146-25-000014 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0000849146-24-000121 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000849146-24-000047 | EDGAR | — |
| 2024-01-30 | 2023-12-31 | 0000849146-24-000016 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000849146-23-000204 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000849146-23-000051 | EDGAR | — |
| 2023-02-02 | 2022-12-31 | 0000849146-23-000015 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000849146-22-000076 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0000849146-22-000027 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-04 | 0001628280-26-005431 | EDGAR | 6K words |
| 2025-12-09 | 0001628280-25-055939 | EDGAR | — |
| 2025-11-12 | 0001628280-25-051641 | EDGAR | — |
| 2025-11-04 | 0001628280-25-048801 | EDGAR | — |
| 2025-09-04 | 0000849146-25-000069 | EDGAR | — |
| 2025-05-06 | 0000849146-25-000041 | EDGAR | — |
| 2025-02-05 | 0000849146-25-000015 | EDGAR | — |
| 2024-11-19 | 0000849146-24-000146 | EDGAR | — |
| 2024-11-14 | 0000849146-24-000142 | EDGAR | — |
| 2024-10-29 | 0000849146-24-000122 | EDGAR | — |
301 total filings indexed. 269 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000849146 |
| Ticker | LFVN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.lifevantage.com |
| Listed | 1997-03-10 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report